January 11, 2024By Matt Fates, Partner and Jeff Knox, Associate Summary The last two decades have seen tremendous expansion of biological…
October 17, 2023Meet Luca Giani, CEO of Ilios Therapeutics, a biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases.
October 4, 2023By Venkat Srinivasan, Managing Director at Innospark Ventures AI is now ubiquitous! Everywhere we turn, we hear people talk about…
August 8, 2023Summary In drug development, new molecular entities get all the press. That’s largely justified – new molecules mean new medicines…
July 26, 2023Meet Roger Sands, CEO of Wyebot, an AI-driven wireless network optimization engine enabling reliable, high-performance WiFi through automated abnormality detection…
July 13, 2023We are thrilled to announce the addition of Eon Mattis to the Innospark Ventures team as an Investment Associate. In…
July 1, 2023Meet George Demosthenous, CEO of Voda.AI, a utility-level water management platform leveraging AI to enable better leak monitoring, risk assessment,…
June 22, 2023Meet Youssef Saleh, CEO of AVA Robotics, an autonomous and intelligent mobile robot platform delivering telepresence, disinfection, and security solutions.- June 14, 2023Even before Generative AI caught fire, computationally aided drug discovery was an area of intense interest for researchers. It should…
May 31, 2023Meet Liz O'Day, CEO of Olaris Therapeutics, a precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response…
